Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection

Patricia Pleguezuelos, Marina Sibila, Raúl Cuadrado-Matías, Rosa López-Jiménez, Diego Pérez, Eva Huerta, Mónica Pérez, Florencia Correa-Fiz, José Carlos Mancera-Gracia, Lucas P. Taylor, Stasia Borowski, Gillian Saunders, Joaquim Segalés, Sergio López-Soria, Mònica Balasch

Open source

DOI: 10.3390/vaccines10081234
Published: 2022-08-01
Container: Vaccines
Publisher: MDPI AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/vaccines10081234,
  title = {Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection},
  author = {Patricia Pleguezuelos and Marina Sibila and Raúl Cuadrado-Matías and Rosa López-Jiménez and Diego Pérez and Eva Huerta and Mónica Pérez and Florencia Correa-Fiz and José Carlos Mancera-Gracia and Lucas P. Taylor and Stasia Borowski and Gillian Saunders and Joaquim Segalés and Sergio López-Soria and Mònica Balasch},
  year = {2022},
  journal = {Vaccines},
  doi = {10.3390/vaccines10081234},
  url = {https://doi.org/10.3390/vaccines10081234}
}

RIS

TY  - JOUR
TI  - Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection
AU  - Patricia Pleguezuelos
AU  - Marina Sibila
AU  - Raúl Cuadrado-Matías
AU  - Rosa López-Jiménez
AU  - Diego Pérez
AU  - Eva Huerta
AU  - Mónica Pérez
AU  - Florencia Correa-Fiz
AU  - José Carlos Mancera-Gracia
AU  - Lucas P. Taylor
AU  - Stasia Borowski
AU  - Gillian Saunders
AU  - Joaquim Segalés
AU  - Sergio López-Soria
AU  - Mònica Balasch
PY  - 2022
JO  - Vaccines
DO  - 10.3390/vaccines10081234
UR  - https://doi.org/10.3390/vaccines10081234
ER  -

APA

Pleguezuelos, P., Sibila, M., Cuadrado-Matías, R., López-Jiménez, R., Pérez, D., Huerta, E., Pérez, M., Correa-Fiz, F., Mancera-Gracia, J. C., Taylor, L. P., Borowski, S., Saunders, G., Segalés, J., López-Soria, S., & Balasch, M. (2022). Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection. Vaccines. https://doi.org/10.3390/vaccines10081234

Source records

crossref · retrieved 2026-11-03T17:18:24.357Z